Study of Safety of QAW039 in Patients With Asthma Inadequately Controlled on Standard-of-care Asthma Treatment
Clinical trial NCT03052517 · TERMINATED
Trial details
- NCT number
- NCT03052517
- Sponsor
- Novartis Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-03-21
- Primary completion
- 2020-02-19
- Enrollment
- 2538
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.